---
figid: PMC8825588__thnov12p1683g002
figtitle: Tumor-derived extracellular vesicles as messengers of natural products in
  cancer treatment
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
pmcid: PMC8825588
filename: thnov12p1683g002.jpg
figlink: /pmc/articles/PMC8825588/figure/F2/
number: F2
caption: The biological function and therapeutic potential of apoptotic bodies. A)
  Apoptotic bodies are secreted by budding directly through the cell membrane. Apoptosis
  leads to an increase in the influx of calcium ions (Ca2+), which triggers proteases,
  and these activated proteases mediate the destruction of the cytoskeleton. ADP-ribosylation
  factor-6 (ARF-6) initiates the signal cascade, and finally activates the rho-related
  protein kinase (ROCK) signaling pathway to trigger blistering, and finally release
  of apoptotic bodies. The initiation of apoptosis also activates apoptotic enzymes
  to mediate the shedding of apoptotic bodies. B) Chemotherapy or radiotherapy-exposed
  tumor cells may initiate apoptosis and trigger the release ABs. Adapted with permission
  from . Copyright Year 2018, frontiers in Immunology. C) Strategies for treatment
  with apoptotic bodies. Adapted with permission from . Copyright Year 2020, PORTLAND
  PRESS. D) Signal pathways affecting tumor cell apoptosis. Adapted with permission
  from . Copyright Year 2020, Springer Nature.
papertitle: Tumor-derived extracellular vesicles as messengers of natural products
  in cancer treatment.
reftext: Yuanxin Xu, et al. Theranostics. 2022;12(4):1683-1714.
year: '2022'
doi: 10.7150/thno.67775
journal_title: Theranostics
journal_nlm_ta: Theranostics
publisher_name: Ivyspring International Publisher
keywords: Tumor-derived extracellular vesicles | Drug delivery systems | Cancer therapy
  | Exosomes | Clinical research progress
automl_pathway: 0.945313
figid_alias: PMC8825588__F2
figtype: Figure
redirect_from: /figures/PMC8825588__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8825588__thnov12p1683g002.html
  '@type': Dataset
  description: The biological function and therapeutic potential of apoptotic bodies.
    A) Apoptotic bodies are secreted by budding directly through the cell membrane.
    Apoptosis leads to an increase in the influx of calcium ions (Ca2+), which triggers
    proteases, and these activated proteases mediate the destruction of the cytoskeleton.
    ADP-ribosylation factor-6 (ARF-6) initiates the signal cascade, and finally activates
    the rho-related protein kinase (ROCK) signaling pathway to trigger blistering,
    and finally release of apoptotic bodies. The initiation of apoptosis also activates
    apoptotic enzymes to mediate the shedding of apoptotic bodies. B) Chemotherapy
    or radiotherapy-exposed tumor cells may initiate apoptosis and trigger the release
    ABs. Adapted with permission from . Copyright Year 2018, frontiers in Immunology.
    C) Strategies for treatment with apoptotic bodies. Adapted with permission from
    . Copyright Year 2020, PORTLAND PRESS. D) Signal pathways affecting tumor cell
    apoptosis. Adapted with permission from . Copyright Year 2020, Springer Nature.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - shrb
  - Vps24
  - ALiX
  - lds
  - Decay
  - mbt
  - Pak
  - LIMK1
  - Arf6
  - sqh
  - Mlc1
  - Mlc2
  - Rok
  - ca
  - mv
  - Sce
  - COM
  - comt
  - compressed
  - lncRNA:flam
  - Apc
  - Apc2
  - Axn
  - Fs(3)Apc
  - Toll-4
  - Tehao
  - Toll-7
  - 18w
  - Toll-6
  - Toll-9
  - MstProx
  - Tl
  - Tollo
  - cib
  - tf
  - COX7AL
  - COX7A
  - ras
  - Ras64B
  - Ras85D
  - Raf
  - Mtor
  - Tor
  - Tie
  - InR
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Dsor1
  - Mtk
  - Erk7
  - rl
  - Pten
  - Debcl
  - Akt
  - Fs(3)Bak
  - Fadd
  - wgn
  - mell
  - SclA
  - Dif
  - dl
  - Rel
  - mei-41
  - put
  - RYa-R
  - ATPsynbeta
  - Atpalpha
  - CkIIbeta
  - Andorra
  - Anp
  - Acam
  - dbo
  - nAChRalpha6
  - Ube3a
  - p53
  - betaTub60D
  - hth
  - tefu
  - Ccp84Ag
  - Myc
  - PDCD6IP
  - NPC1
  - ERVK-8
  - ERVK-10
  - ERVK-9
  - ERVK-21
  - ERVK-18
  - ERVK-25
  - ERVK-24
  - ERVK-19
  - PAK2
  - PKN2
  - ARF6
  - MLC1
  - ROCK1
  - ROCK2
  - NT5E
  - APC
  - PROC
  - TLR4
  - CIB1
  - ABHD14B
  - TF
  - KRAS
  - HRAS
  - NRAS
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - MTOR
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - F10
  - EPHB2
  - MAPK1
  - MAPK3
  - PTEN
  - BCL2
  - AKT1
  - AKT2
  - AKT3
  - BID
  - FGA
  - FGB
  - FGG
  - BAK1
  - BAX
  - FADD
  - CASP1
  - CASP2
  - CASP4
  - CASP5
  - CASP6
  - CASP8
  - CASP9
  - CASP10
  - CASP12
  - CASP14
  - CASP3
  - CASP7
  - TNFRSF1A
  - TNFSF10
  - PRDM16
  - NFKB1
  - RELA
  - RELB
  - REL
  - NFKB2
  - ATR
  - ANTXR1
  - MMAB
  - SERPINA2
  - F2RL1
  - NR1I2
  - SLC52A1
  - CD274
  - ATP8A2
  - CTLA4
  - PDCD1
  - RPL17
  - SNCA
  - SPATA2
  - RPL17-C18orf32
  - DIABLO
  - XIAP
  - FOXO3
  - DDIT3
  - TP53
  - TP63
  - TP73
  - ATM
  - C1QA
  - C1QB
  - C1QC
  - C1R
  - C1S
  - C2
  - MYC
---
